Virios Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIRI and other ETFs, options, and stocks.

About VIRI

Virios Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. It offers IMC-1 a novel, proprietary, fixed dose combination of famciclovir and celecoxib. 

CEO
Greg Duncan
CEOGreg Duncan
Employees
5
Employees5
Headquarters
Alpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded
2012
Founded2012
Employees
5
Employees5

VIRI Key Statistics

Market cap
6.82M
Market cap6.82M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
969.88K
Average volume969.88K
High today
$0.395
High today$0.395
Low today
$0.37
Low today$0.37
Open price
$0.39
Open price$0.39
Volume
430.78K
Volume430.78K
52 Week high
$9.11
52 Week high$9.11
52 Week low
$0.3408
52 Week low$0.3408

VIRI Earnings

-$0.69
-$0.46
-$0.23
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, Pre-Market
ActualExpected Nov 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.